Clinical trial
Optical Coherence Tomography for EVERolimus Eluting STent (OCTEVEREST)
NCT01146080 is registered in ClinicalTrials.gov with A.O. Ospedale Papa Giovanni XXIII as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optical Coherence Tomography for EVERolimus Eluting STent (OCTEVEREST)
- Lead sponsor
- A.O. Ospedale Papa Giovanni XXIII
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- October 31, 2015
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.